jane first of all if you listen to the call they are not planning on developing this drug on their own what so ever. They already know they can't market this. second why are so #$%$ off? This company has so much money in the tank that there is nothing to worry about, they have only 60 people in the whole company. There is no china effect for this company, there is no dollar collapse effect for this comopany, just sunshine...
More Phase 1's on other childhood epilepsy coming. One will start 4th q. Any efficacy on this should be very positive.
Very nice...Royalties from Purdue and any Pernix milestone payments would be sugar on top. Zohydro just got approved by Express scripts for next year.
GW's last presentation has a whole slew of epilepsy conditions that their going after and in their open label studies they only had some percentage reduction in epilepsy, Brabafen, on the other hand a large percentage of the seizure free population in their open label study with verified DNA relationship on majority of those patients.
Zogenix has 177 million in liquid assets to figure that out.
Say you don't believe the body of work done that shows low dose Fenflueramine is effective in treating epilepsy and say you got a hold of some Fenflueramine and gave it to a dravet infant and saw its dramatic effect, would you be considered having insider information or is it due diligence? How hard is it for someone who invests 20million, 50 million or 100million in Zogenix to do this?
I suspected as much you are long. I had an uncle like you. This is Farr's company now and so far he has done pretty well for us.
hedging2win you are having a nervous breakdown. Catch your breath, relax.